中国当代医药2024,Vol.31Issue(12) :52-56.

艾灸联合厄贝沙坦片治疗糖尿病肾病Ⅲ、Ⅳ期的临床观察

Clinical observation of moxibustion combined with Irbesartan Tablets in the treatment of diabetic nephropathy stage Ⅲ and Ⅳ

邱悦 虞成毕 周文娣
中国当代医药2024,Vol.31Issue(12) :52-56.

艾灸联合厄贝沙坦片治疗糖尿病肾病Ⅲ、Ⅳ期的临床观察

Clinical observation of moxibustion combined with Irbesartan Tablets in the treatment of diabetic nephropathy stage Ⅲ and Ⅳ

邱悦 1虞成毕 1周文娣1
扫码查看

作者信息

  • 1. 江西省九江市中医医院内分泌科,江西九江 332000
  • 折叠

摘要

目的 探讨糖尿病肾病(DKD)Ⅲ、Ⅳ期患者应用艾灸联合厄贝沙坦片治疗的效果.方法 选取2020年8月至2021年8月于九江市中医医院就诊的80例DKD患者为研究对象,采用随机数字表法分为对照组和观察组,每组各40例.对照组予以基础治疗,并口服厄贝沙坦片,观察组加用艾灸治疗.比较两组的临床疗效、中医证候积分、血糖水平、炎症因子水平、生化指标及不良反应.结果 观察组的临床总有效率高于对照组,差异有统计学意义(P<0.05);观察组治疗后的中医证候积分低于对照组,差异有统计学意义(P<0.05);血糖方面,空腹血糖(FPG)、餐后2 h血糖(2hPG)低于对照组,差异有统计学意义(P<0.05);炎症因子方面,肿瘤坏死因子α(TNF-α)、超敏C反应蛋白(hs-CRP)和白介素-6(IL-6)水平低于对照组,差异有统计学意义(P<0.05);生化指标方面,尿素氮(BUN)、血肌酐(Scr)、24 h尿蛋白定量(mALB)、尿微量白蛋白(MAU)、尿白蛋白/肌酐比值(ACR)、尿视黄醇结合蛋白(RBP)水平低于对照组,差异有统计学意义(P<0.05).两组未见明显不良反应.结论 DKD Ⅲ、Ⅳ期患者应用艾灸联合厄贝沙坦片治疗可改善血糖水平及肾功能,缓解临床症状,减轻炎症反应,效果确切,安全性好,值得推广.

Abstract

Objective To investigate the effect of moxibustion combined with Irbesartan Tablets on diabetic nephropathy(DKD)patients in stage Ⅲ and Ⅳ.Methods A total of 80 DKD patients treated in Jiujiang Hospital of Traditional Chinese Medicine from August 2020 to August 2021 were selected as the study objects,and were divided into control group and ob-servation group by random number table method,with 40 cases in each group.The control group was treated with basic treatment and oral Irbesartan Tablets,and the observation group was added with moxibustion.The clinical efficacy,tradi-tional Chinese medicine syndrome score,blood glucose level,inflammatory factor level,biochemical indexes and adverse re-actions were compared between the two groups.Results The total clinical effective rate of the observation group was higher than that of the control group,the difference was statistically significant(P<0.05).The traditional Chinese medicine syn-drome scores of the observation group after treatment were lower than those of the control group,and the differences were statistically significant(P<0.05).In terms of blood glucose,fasting blood glucose(FPG)and 2 h postprandial blood glucose(2 hPG)were lower than those in control group,with statistical significances(P<0.05).In terms of inflammatory factors,the levels of tumor necrosis factor α(TNF-α),hypersensitive C-reactive protein(hs-CRP)and interleukin-6(IL-6)were lower than those of control group,with statistical significances(P<0.05).In terms of biochemical indexes,the levels of urea nitrogen(BUN),blood creatinine(Scr),24 h urinary protein quantity(mALB),urinary microalbumin(MAU),urinary albu-min/creatinine ratio(ACR)and urinary retinol binding protein(RBP)were lower than those of control group,and the differ-ences were statistically significants(P<0.05).No obvious adverse reactions were observed in the two groups.Conclusion The application of moxibustion combined with Irbesartan Tablets in the treatment of patients with DKD Ⅲ and Ⅳ can im-prove blood glucose level and renal function,relieve clinical symptoms,reduce inflammatory reaction,with exact effect and good safety,which is worthy of promotion.

关键词

糖尿病肾病/艾灸/厄贝沙坦片/血糖水平/炎症因子水平/生化指标

Key words

Diabetic nephropathy/Moxibustion/Irbesartan Tablets/Blood glucose levels/Levels of inflammatory factors/Biochemical indicators

引用本文复制引用

基金项目

江西省中医药局科技项目(2021B549)

出版年

2024
中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
参考文献量23
段落导航相关论文